Tumour vessels exhibit an enhanced, VEGF-A induced, vascular permeability and kinetics of extravasation of several circulating proteins are enhanced in cancer patients, e.g. fibrinogen (Dvorak et al, 1984). The gene discussed is VEGFA; the disease is cancer.